1. 06:00
  2. 07:00
  3. 08:00
  4. 09:00
  5. 10:00
  6. 11:00
  7. 12:00
  8. 13:00
  9. 14:00
  10. 15:00
  11. 16:00
  12. 17:00
  13. 18:00
  14. 19:00
  15. 20:00
  16. 21:00
  1. Sala 500

  2. Sala Madrid

  3. Sala Londra

  4. Catering and Exhibition

    1. 06:00
    2. 07:00
    3. 08:00
    4. 09:00
    5. 10:00
    6. 11:00
    7. 12:00
    8. 13:00
    9. 14:00
    10. 15:00
    11. 16:00
    12. 17:00
    13. 18:00
    14. 19:00
    15. 20:00
    16. 21:00
  1. Sala 500

    1. Plenary Session 0 - Introduction to the meeting and its format

      Introduction to the meeting and its format Plenary Session 0

      08:00 - 08:15

    2. Plenary Session 3 - Pathological assessment and molecular staging

      Pathological assessment and molecular staging Plenary Session 3

      08:00 - 09:00

    3. Plenary Session 1 - Muscle Invasive Bladder Cancer (MIBC)

      Muscle Invasive Bladder Cancer (MIBC) Plenary Session 1

      08:15 - 09:00

    4. Case Discussion 1

      • Open or robotic radical cystectomy? (Duel)
      • Is there an oncological benefit of an extended lymphadenectomy in bladder cancer?
      • Choice of urinary diversion: An interdisciplinary perspective

      Case Discussion 1

      09:00 - 12:30

    5. Case Discussion 3

      • Non-urothelial and aberrant urothelial histology: Its prognosis and impact on treatment decisions
      • Radical cystectomy: How to handle the complications?
      • Management and follow-up of low and intermediate risk tumours

      Case Discussion 3

      09:00 - 12:30

    6. Plenary Session 2 - Non-Muscle Invasive Bladder Cancer (NMIBC)

      Non-Muscle Invasive Bladder Cancer (NMIBC) Plenary Session 2

      13:30 - 14:00

    7. Plenary Session 4 - What´s new in diagnosing and staging of urothelial cancer?

      What´s new in diagnosing and staging of urothelial cancer? Plenary Session 4

      13:30 - 14:00

    8. Case Discussion 2

      • Sophisticated tumour visualisation: Clinical and prognostic implications
      • Standard and new techniques of TURBT
      • Adjuvant treatment in NMIBC: Where are we?

      Case Discussion 2

      14:00 - 17:30

    9. Plenary Session 5 - Update on medical therapies

      Update on medical therapies Plenary Session 5

      14:00 - 14:45

    10. Plenary Session 6 - Panel case discussion: Critical decision making in NMIBC

      Panel case discussion: Critical decision making in NMIBC Plenary Session 6

      14:45 - 15:30

    11. Plenary Session 7 - Close

      Close Plenary Session 7

      15:30 - 15:40

  2. Sala Madrid

    1. Case Discussion 1

      • Is there an oncological benefit of an extended lymphadenectomy in bladder cancer?
      • Choice of urinary diversion: A interdisciplinary perspective
      • Open or robotic radical cystectomy? (Duel)

      Case Discussion 1

      09:00 - 12:30

    2. Case Discussion 3

      • Radical cystectomy: How to handle the complications?
      • Management and follow-up of low and intermediate risk tumours
      • Non-urothelial and aberrant urothelial histology: Its prognosis and impact on treatment decisions

      Case Discussion 3

      09:00 - 12:30

    3. Case Discussion 2

      • Standard and new techniques of TURBT
      • Adjuvant treatment in NMIBC: Where are we?
      • Sophisticated tumour visualisation: Clinical and prognostic implications

      Case Discussion 2

      14:00 - 17:30

  3. Sala Londra

    1. Case Discussion 1

      • Choice of urinary diversion: A interdisciplinary perspective
      • Open or robotic radical cystectomy? (Duel)
      • Is there an oncological benefit of an extended lymphadenectomy in bladder cancer?

      Case Discussion 1

      09:00 - 12:30

    2. Case Discussion 3

      • Management and follow-up of low and intermediate risk tumours
      • Non-urothelial and aberrant urothelial histology: Its prognosis and impact on treatment decisions
      • Radical cystectomy: How to handle the complications?

      Case Discussion 3

      09:00 - 12:30

    3. Case Discussion 2

      • Adjuvant treatment in NMIBC: Where are we?
      • Sophisticated tumour visualisation: Clinical and prognostic implications
      • Standard and new techniques of TURBT

      Case Discussion 2

      14:00 - 17:30

  4. Catering and Exhibition

    1. Break - Coffee break

      Coffee break Break

      10:00 - 10:30

    2. Break - Coffee break

      Coffee break Break

      10:00 - 10:30

    3. Break - Lunch

      Lunch Break

      12:30 - 13:30

    4. Break - Lunch

      Lunch Break

      12:30 - 13:30

    5. Break - Coffee break

      Coffee break Break

      16:00 - 16:30